Results 181 to 190 of about 3,650 (207)
Some of the next articles are maybe not open access.

Safety of depot medroxyprogesterone acetate

The Lancet, 1991
MichèleG Bonhomme   +3 more
openaire   +1 more source

Depot medroxyprogesterone acetate pioneers

Contraception, 1997
Linda S. Potter   +3 more
openaire   +1 more source

Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate

Fertility and Sterility, 2006
M Kathleen Clark   +2 more
exaly  

Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate

Contraception, 2014
Katharine O'Connell White   +2 more
exaly  

Use of depot medroxyprogesterone acetate contraception in adolescents.

The Journal of reproductive medicine, 1996
More than 1 million teen pregnancies occur each year in the United States. DMPA offers several distinct advantages over other contraceptive methods in adolescents. The duration of effectiveness and convenience of DMPA are appealing to teens. Most teens who are current users view amenorrhea as a positive feature of DMPA.
openaire   +1 more source

Optimising the use of depot medroxyprogesterone acetate

Drugs & Therapy Perspectives, 1994
openaire   +1 more source

Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception

American Journal of Obstetrics and Gynecology, 2002
Tim Cundy, Helen Roberts, Ian R Reid
exaly  

Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum

European Journal of Contraception and Reproductive Health Care, 2005
M Sönmezer, Fulya DÖKMECİ
exaly  

Home - About - Disclaimer - Privacy